Proxy Statement Details Strong 2025 Performance, $1.5B Capital Raise, and Executive Compensation
AHR sits 85% above its 52-week low of $26.48.
Summary
American Healthcare REIT filed its definitive proxy statement for the 2026 Annual Meeting, detailing strong 2025 financial performance including a return to GAAP net income, significant FFO and Same-Store NOI growth, and successful capital raises totaling $1.5 billion.
Key Events · Corporate Governance and Compliance · AHR
-
Annual Meeting Details
The company will hold its 2026 Annual Meeting of Stockholders on June 24, 2026, to vote on the election of nine directors, ratification of Deloitte & Touche LLP as auditor, and an advisory vote on executive compensation.
-
Strong 2025 Financial Performance
American Healthcare REIT reported a significant financial rebound in 2025, achieving GAAP net income of $69.8 million (vs. a $37.8 million net loss in 2024), Normalized FFO of $1.72 per diluted share (up from $1.41), and 14.2% Same-Store Net Operating Income growth.
-
Successful Capital Raises and Balance Sheet Improvement
The company raised $1.5 billion in gross proceeds from three public offerings in 2025 and improved its Net Debt-to-Adjusted EBITDA ratio from 4.3x to 3.4x, enhancing financial flexibility.
-
Executive Compensation Aligned with Performance
Named Executive Officers received maximum cash bonuses (150% of target) and 200% of target for performance-based RSUs for the 2023-2025 period, reflecting the company's strong financial and operational achievements.
Analysis · AHR · Real Estate & Construction
This definitive proxy statement provides comprehensive insights into American Healthcare REIT's governance, executive compensation, and, notably, its strong financial and operational performance for 2025. The significant turnaround to GAAP net income, substantial growth in FFO and Same-Store NOI, and successful capital raises totaling $1.5 billion highlight a very positive year for the company. The executive compensation structure is clearly linked to these performance metrics, resulting in high payouts for achieving maximum targets. Investors should review the proposals for the upcoming annual meeting, particularly the election of directors and the advisory vote on executive compensation, in light of the company's recent strong performance and strategic capital management.
At the time of this filing, AHR was trading at $49.11 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $9.2B. The 52-week trading range was $26.48 to $54.67. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.